![Asia stocks mixed with gains in China shares, RBI cuts rate as expected](https://i-invdn-com.investing.com/news/moved_small-LYNXNPEC4Q0AP_L.jpg)
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1046 | 989 | 1046 | 1017 | 1161 | 1410 |
Fund Return | 4.58% | -1.14% | 4.58% | 0.57% | 3.03% | 3.49% |
Place in category | 113 | 85 | 113 | 86 | 72 | 51 |
% in Category | 50 | 44 | 50 | 37 | 54 | 60 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
PIMegatrend Selection R EUR | 11.9B | 13.10 | 0.34 | 7.19 | ||
LU0474970273 | 11.9B | 3.94 | -5.23 | 3.30 | ||
LU0474969937 | 11.9B | 5.83 | -3.51 | 5.13 | ||
Pictet Global Megatrend Selection e | 11.9B | 14.14 | 1.25 | 8.15 | ||
Pictet-Global Megatrend Sel HP EUR | 11.9B | 4.89 | -4.37 | 4.24 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1120766388 | 1.38B | 9.35 | 5.89 | - | ||
Pictet Biotech I EUR | 1.43B | 6.27 | 2.19 | 5.11 | ||
Pictet Biotech P EUR | 1.43B | 5.32 | 1.28 | 4.22 | ||
FCP MEDICAL BioHealth-Trends EUR | 706.83M | 7.95 | 6.10 | 9.50 | ||
FCP MEDICAL BioHealth Trends I | 706.83M | 8.48 | 6.63 | 10.48 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
argenx ADR | US04016X1019 | 5.68 | 657.97 | -2.05% | |
Gilead | US3755581036 | 4.61 | 98.04 | -1.62% | |
Insmed | US4576693075 | 4.45 | 80.78 | -0.81% | |
Sarepta | US8036071004 | 4.12 | 112.11 | -5.81% | |
Intracellular Th | US46116X1019 | 4.07 | 127.12 | +0.07% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review